SM

Soumi Mitra

Active Director Director DIN 09798749
DIN 09798749 First appointment Nov 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2022
Shareholding value Locked Premium profile

About Soumi Mitra

Soumi Mitra has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Cure24 Medico Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09798749
Primary Designation Director
First Appointment 22 Nov 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Cure24 Medico Private Limited U52398WB2022PTC258344
Director22 Nov 20222022Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cure24 Medico Private Limited
Premium access

Shareholding and investment profile for Soumi Mitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soumi Mitra

Soumi Mitra has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Cure24 Medico Private Limited. Engaged in General Business. Contributes to corporate operations.

Soumi Mitra is associated with 1 company as Director.

Soumi Mitra has expertise in General Business.

Soumi Mitra has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available